Centene (CNC) Competitors $29.14 -0.26 (-0.87%) As of 02:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNC vs. ELV, MOH, SEM, HUM, UNH, CI, JYNT, AEMD, EW, and TAKShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Humana (HUM), UnitedHealth Group (UNH), Cigna Group (CI), Joint (JYNT), Aethlon Medical (AEMD), Edwards Lifesciences (EW), and Takeda Pharmaceutical (TAK). These companies are all part of the "medical" sector. Centene vs. Its Competitors Elevance Health Molina Healthcare Select Medical Humana UnitedHealth Group Cigna Group Joint Aethlon Medical Edwards Lifesciences Takeda Pharmaceutical Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends. Do insiders & institutionals hold more shares of ELV or CNC? 89.2% of Elevance Health shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.3% of Elevance Health shares are held by company insiders. Comparatively, 0.4% of Centene shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate ELV or CNC? Elevance Health presently has a consensus target price of $413.81, suggesting a potential upside of 32.36%. Centene has a consensus target price of $42.20, suggesting a potential upside of 44.51%. Given Centene's higher possible upside, analysts clearly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elevance Health 0 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.67Centene 1 Sell rating(s) 13 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.12 Which has more risk and volatility, ELV or CNC? Elevance Health has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Centene has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Is ELV or CNC more profitable? Elevance Health has a net margin of 2.83% compared to Centene's net margin of 1.15%. Elevance Health's return on equity of 17.59% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Elevance Health2.83% 17.59% 6.36% Centene 1.15%9.57%3.10% Does the media favor ELV or CNC? In the previous week, Centene had 61 more articles in the media than Elevance Health. MarketBeat recorded 96 mentions for Centene and 35 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.24 beat Centene's score of 0.38 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 26 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Positive Centene 28 Very Positive mention(s) 8 Positive mention(s) 39 Neutral mention(s) 10 Negative mention(s) 4 Very Negative mention(s) Neutral Which has stronger earnings & valuation, ELV or CNC? Elevance Health has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElevance Health$177.01B0.40$5.98B$23.5013.30Centene$178.19B0.08$3.31B$4.047.23 SummaryElevance Health beats Centene on 11 of the 16 factors compared between the two stocks. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneMED IndustryMedical SectorNYSE ExchangeMarket Cap$14.33B$41.90B$5.76B$20.89BDividend YieldN/A100.37%4.53%3.60%P/E Ratio7.2210.0930.4328.30Price / Sales0.080.71392.2152.84Price / Cash2.968.5437.0323.77Price / Book0.522.349.015.18Net Income$3.31B$2.64B$3.26B$992.10M7 Day Performance8.43%15.68%1.00%-0.36%1 Month Performance6.58%11.73%4.19%1.14%1 Year Performance-62.75%-34.02%28.39%10.37% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.8571 of 5 stars$29.15-0.9%$42.20+44.8%-62.4%$14.33B$178.19B7.2260,500Trending NewsAnalyst RevisionELVElevance Health4.8649 of 5 stars$290.80-1.1%$418.19+43.8%-42.8%$65.48B$177.01B12.37104,200News CoveragePositive NewsMOHMolina Healthcare4.9452 of 5 stars$153.84-1.9%$244.55+59.0%-50.1%$8.34B$43.41B7.5818,000Positive NewsShort Interest ↑SEMSelect Medical4.9943 of 5 stars$12.06-0.1%$24.60+104.0%-60.8%$1.50B$5.28B11.3844,100Analyst RevisionHUMHumana4.25 of 5 stars$267.19+0.2%$281.62+5.4%-18.7%$32.13B$117.76B20.5165,680Positive NewsAnalyst ForecastAnalyst RevisionUNHUnitedHealth Group4.9616 of 5 stars$252.44+0.6%$366.52+45.2%-48.4%$229.00B$422.82B10.94400,000Trending NewsAnalyst ForecastCICigna Group4.9993 of 5 stars$277.16+0.8%$377.72+36.3%-11.2%$73.98B$247.12B15.1373,500Positive NewsInsider TradeJYNTJoint4.0013 of 5 stars$10.80+0.6%$16.33+51.2%-9.2%$165.24M$51.90M-32.73320Positive NewsInsider TradeAEMDAethlon Medical2.4417 of 5 stars$1.24+0.8%$56.00+4,416.1%-70.1%$3.21MN/A-0.1010Analyst RevisionGap UpEWEdwards Lifesciences4.4632 of 5 stars$78.23-0.2%$85.90+9.8%+17.2%$45.93B$5.44B11.2615,800Positive NewsInsider TradeAnalyst RevisionTAKTakeda Pharmaceutical1.543 of 5 stars$14.43-0.1%N/A+4.8%$45.90B$30.09B48.0847,455News CoveragePositive NewsShort Interest ↑ Related Companies and Tools Related Companies ELV Alternatives MOH Alternatives SEM Alternatives HUM Alternatives UNH Alternatives CI Alternatives JYNT Alternatives AEMD Alternatives EW Alternatives TAK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNC) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.